---
figid: PMC6863963__fonc-09-01235-g0001
figlink: /pmc/articles/PMC6863963/figure/F1/
number: F1
caption: Conflicting roles of RASAL2 in different cancers. (A) RASAL2 inhibits angiogenesis,
  invasion and metastasis of several types of cancer cells. In luminal B breast cancer,
  the loss of RASAL2 activates wild-type RAS and then increases MEK (mitogen-activated
  protein kinase kinase)/ERK (extracellular regulated protein kinases) and PI3K (phosphoinositide
  3-kinase)/AKT (a serine/threonine-specific protein kinase) signaling to promote
  invasion, and it induces NF-kB activation to promote epithelial–mesenchymal transition
  (EMT). In lung adenocarcinoma, the loss of RASAL2 promotes migration capability
  via EMT through ERK regulation. In ovarian cancer, the loss of RASAL2 activates
  the RAS-ERK pathway, leading to EMT. In renal cell carcinoma (RCC), RASAL2 reduces
  Serine9 (Ser9) phosphorylation to activate glycogen synthase kinase-3 β (GSK3β)
  and then decreases the expression of c-FOS and vascular endothelial growth factor
  A (VEGFA) to suppress RCC cells. In bladder cancer, RASAL2 depletion enhances the
  phosphorylation of AKT and then upregulates the expression of ETS proto-oncogene
  1 (ETS1) and VEGFA, leading to angiogenesis. RASAL2 also downregulates sex-determining
  region Y-box 2 (SOX2) and CD44 expression by inhibiting the ERK/mitogen-activated
  protein kinases (MAPK) pathway to induce cancer stemness. (B) RASAL2 promotes invasion
  and metastasis of several types of cancer cells. In triple-negative breast cancer
  (TNBC), miR-136 and miR-203 downregulate RASAL2 to suppress cell migration, EMT
  and invasion. The activation of a RASAL2/ARHGAP24 (Rho GTPase activating protein
  24)/RAC1 (RAS-related C3 botulinum toxin substrate 1) module contributes to TNBC
  tumorigenesis. RASAL2 is hypomethylated and promotes invasiveness in HCC. Downregulation
  of RASAL2 alters the phosphorylation of the effectors of the MAPK, WNT/β-catenin,
  and PI3K/AKT/mTOR signaling pathways and then impairs these pathways. RASAL2 is
  also the target of miR-203 in HCC cells. In colorectal cancer (CRC), importin-5
  (IPO5) binds to the nuclear localization signal or sequence (NLS) sequence of RASAL2,
  which induces RAS signal activation. RASAL2 is also involved in the Hippo signaling
  pathway, which promotes tumorigenesis and metastasis by inhibiting the expression
  of large tumor suppressor kinase 2 (LATS2) and then increasing the expression of
  yes-associated protein 1 (YAP1) in CRC.
pmcid: PMC6863963
papertitle: RASAL2 Plays Inconsistent Roles in Different Cancers.
reftext: Bolun Zhou, et al. Front Oncol. 2019;9:1235.
pmc_ranked_result_index: '53001'
pathway_score: 0.8957524
filename: fonc-09-01235-g0001.jpg
figtitle: Conflicting roles of RASAL2 in different cancers
year: '2019'
organisms:
- Homo sapiens
ndex: a080b224-df14-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6863963__fonc-09-01235-g0001.html
  '@type': Dataset
  description: Conflicting roles of RASAL2 in different cancers. (A) RASAL2 inhibits
    angiogenesis, invasion and metastasis of several types of cancer cells. In luminal
    B breast cancer, the loss of RASAL2 activates wild-type RAS and then increases
    MEK (mitogen-activated protein kinase kinase)/ERK (extracellular regulated protein
    kinases) and PI3K (phosphoinositide 3-kinase)/AKT (a serine/threonine-specific
    protein kinase) signaling to promote invasion, and it induces NF-kB activation
    to promote epithelial–mesenchymal transition (EMT). In lung adenocarcinoma, the
    loss of RASAL2 promotes migration capability via EMT through ERK regulation. In
    ovarian cancer, the loss of RASAL2 activates the RAS-ERK pathway, leading to EMT.
    In renal cell carcinoma (RCC), RASAL2 reduces Serine9 (Ser9) phosphorylation to
    activate glycogen synthase kinase-3 β (GSK3β) and then decreases the expression
    of c-FOS and vascular endothelial growth factor A (VEGFA) to suppress RCC cells.
    In bladder cancer, RASAL2 depletion enhances the phosphorylation of AKT and then
    upregulates the expression of ETS proto-oncogene 1 (ETS1) and VEGFA, leading to
    angiogenesis. RASAL2 also downregulates sex-determining region Y-box 2 (SOX2)
    and CD44 expression by inhibiting the ERK/mitogen-activated protein kinases (MAPK)
    pathway to induce cancer stemness. (B) RASAL2 promotes invasion and metastasis
    of several types of cancer cells. In triple-negative breast cancer (TNBC), miR-136
    and miR-203 downregulate RASAL2 to suppress cell migration, EMT and invasion.
    The activation of a RASAL2/ARHGAP24 (Rho GTPase activating protein 24)/RAC1 (RAS-related
    C3 botulinum toxin substrate 1) module contributes to TNBC tumorigenesis. RASAL2
    is hypomethylated and promotes invasiveness in HCC. Downregulation of RASAL2 alters
    the phosphorylation of the effectors of the MAPK, WNT/β-catenin, and PI3K/AKT/mTOR
    signaling pathways and then impairs these pathways. RASAL2 is also the target
    of miR-203 in HCC cells. In colorectal cancer (CRC), importin-5 (IPO5) binds to
    the nuclear localization signal or sequence (NLS) sequence of RASAL2, which induces
    RAS signal activation. RASAL2 is also involved in the Hippo signaling pathway,
    which promotes tumorigenesis and metastasis by inhibiting the expression of large
    tumor suppressor kinase 2 (LATS2) and then increasing the expression of yes-associated
    protein 1 (YAP1) in CRC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - CD44
  - FOS
  - MAPK3
  - MAPK1
  - ETS1
  - GSK3B
  - IPO5
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK12
  - MAP2K1
  - MAP2K2
  - MTOR
  - NFKB1
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3R3
  - PIK3CG
  - PIK3R6
  - RAF1
  - ARAF
  - BRAF
  - KRAS
  - HRAS
  - NRAS
  - RASAL2
  - SOX2
  - TSC2
  - VEGFA
  - WNT11
  - CTNNB1
  - WNT16
  - WNT4
  - WNT1
  - WNT2
  - WNT3
  - WNT5A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT5B
  - WNT3A
  - Ser
  - GDP
  - breast cancer
  - carcinoma
  - bladder cancer
  - ovarian cancer
  - metastasis breast cancer
  - colorectal cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: c-FOS
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ETS1
  symbol: ETS1
  source: hgnc_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: Gsk3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: IPO5
  symbol: IPO5
  source: hgnc_symbol
  hgnc_symbol: IPO5
  entrez: '3843'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RASAL2
  symbol: RASAL2
  source: hgnc_symbol
  hgnc_symbol: RASAL2
  entrez: '9462'
- word: SOX2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT/B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT/B-catenin
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
chemicals:
- word: Ser
  source: MESH
  identifier: C530429
- word: GDP
  source: MESH
  identifier: D006153
diseases:
- word: breast cancer
  source: MESH
  identifier: D001943
- word: carcinoma
  source: MESH
  identifier: D002277
- word: bladder cancer
  source: MESH
  identifier: D001749
- word: ovarian cancer
  source: MESH
  identifier: D010051
- word: metastasis breast cancer
  source: MESH
  identifier: D009362
- word: colorectal cancer
  source: MESH
  identifier: D015179
figid_alias: PMC6863963__F1
redirect_from: /figures/PMC6863963__F1
figtype: Figure
---
